Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Megalabs Colombia is a leading pharmaceutical company and a key subsidiary of the Megalabs group, one of the largest healthcare conglomerates in Latin America. The company specializes in the commercialization and distribution of a broad portfolio of branded generic medications across multiple therapeutic areas, including cardiology, gastroenterology, and respiratory health. A significant pillar of its business is the dermatology segment, operated under the well-known Medihealth brand, which provides specialized treatments for skin conditions. Megalabs Colombia leverages the group's extensive regional manufacturing and R&D infrastructure to deliver high-quality, accessible healthcare solutions. The company maintains a robust commercial presence in the Andean region through a large network of medical representatives and strategic partnerships with international pharmaceutical firms. Its operations are characterized by a strong focus on innovation in drug delivery and therapeutic efficacy tailored to the Latin American market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Megalabs Colombia.